Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 1/20 | 0.40 |
| ▸ | RET | P07949 | 7/20 | 0.39 |
| ▸ | GPR119 | Q8TDV5 | 1/20 | 0.36 |
| ▸ | HCRTR2 | O43614 | 6/20 | 0.35 |
| ▸ | HCRTR1 | O43613 | 5/20 | 0.35 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.35 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.35 |
| ▸ | PDE10A | Q9Y233 | 1/20 | 0.33 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29749185 | 0.88 | PDE10A (0.41) | ACACBRETGPR119PDE10A | |
| SCHEMBL26919352 | 0.87 | ACACB (0.39) | ACACBRETHCRTR2HCRTR1 | |
| SCHEMBL29782973 | 0.81 | ACACB (0.44) | ACACBRETHDAC1 | |
| SCHEMBL31370459 | 0.70 | PDE10A (0.50) | ACACBRETPDE10A | |
| SCHEMBL31144052 | 0.70 | HCRTR2 (0.38) | ACACBRETHCRTR2HCRTR1 | |
| SCHEMBL28701004 | 0.70 | HCRTR2 (0.38) | ACACBRETHCRTR2HCRTR1 | |
| SCHEMBL29749147 | 0.69 | RET (0.53) | ACACBRETPDE10A | |
| SCHEMBL31274442 | 0.68 | PDE10A (0.50) | ACACBGPR119HCRTR2HCRTR1HDAC1 | |
| SCHEMBL928501 | 0.68 | PDE10A (0.50) | ACACBGPR119HCRTR2HCRTR1HDAC1 | |
| SCHEMBL22795888 | 0.68 | PDE10A (0.50) | ACACBGPR119HCRTR2HCRTR1HDAC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022166642-A1 | NITROGEN-CONTAINING POLYCYCLIC FUSED RING COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, PREPARATION METHOD THEREFOR, AND USE THEREOF | 北京志健金瑞生物医药科技有限公司 | 2022-08-11 | — | — | WO | disclosed |